Podcasts

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Articles

Recommended medicines include treatments for generalized myasthenia gravis, glioma, neovascular age-related macular degeneration, and more.

EMA Recommends Rare Blood Cancer Treatment and Seven Other Medicines

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.

Discussing the Origins of the mRNA Therapeutics Field (Part One)

Electronic product information for selected human medicines that have been harmonized across the European Union have been published for the first time.

Europe Publishes Electronic Product Information for Selected Medicines

The document includes recommendations for the reporting and implementation of changes to container closure system components.

FDA Publishes Guidance on Container Closure Systems for COVID-19 

Feliza Mirasol is the science editor for 

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights how current technologies are enabling oligonucleotide development.

Oligonucleotide-Enabling Technology Pushes Oligos to the Forefront (AAPS PharmSci 360)

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation, considers that status of oligonucleotides on the market.

Oligonucleotides: The Next Therapeutic Wave on the Market? (AAPS PharmSci 360)

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights the company’s motivation behind their new bioanalysis kit for oligonucleotides.

The Need for New Bioanalysis Technology (AAPS PharmSci 360)

Videos

Chris Spivey, editorial director for Pharmaceutical Technology®, discusses mRNA advances and the background for the leading scientific conference for the field, with host and co-organizer CureVac CEO Dr. Alexander Zehnder. 

mRNA: Unparalleled Potential as a Drug

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation discusses the analytical and downstream purification challenges of oligonucleotides.

News